gluconic acid: Clinical Trials

9 trials of gluconic acid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 active not recruiting, 1 withdrawn. 9 Phase 2, 3 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 29Completed 7, Active not recruiting 1, Withdrawn 1
Phase 33Completed 3
Phase 12Completed 2

Follow gluconic acid: new trials by email Literature Review of gluconic acid trials Research Report on gluconic acid

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
Amivantamab IV, Amivantamab SC, Lazertinib - Carcinoma, Non-Small-Cell Lung
Phase 2Active not recruitingJanssen Research & Development, LLC3052024-02-162026-09-25
Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia
Zinc gluconate supplement, Botulinum toxin type A - Spasmodic Dysphonia
Phase 1 / Phase 2CompletedUniversity of Florida322023-08-012026-07-27
Zinc Intervention in Elderly for Prevention of Pneumonia
Zinc gluconate - Zinc Deficiency
Phase 2 / Phase 3CompletedTufts University1052022-05-032024-07-30
Fluid Therapy During Brain Tumor Resection in Children
balanced crystalloid solution (components: sodium chloride, sodium gluconate, sodium acetate, potassium chloride and magnesium chloride), 0.9% sodium chloride - Brain Neoplasms
Phase 2CompletedFederal University of São Paulo532015-08-012017-11-14
Oral Zinc Gluconate as Treatment for Recalcitrant Cutaneous Warts: A Randomized, Double-blind, Placebo-controlled Trial
Zinc gluconate, Corn starch pill - Recalcitrant Cutaneous Warts
Phase 2 / Phase 3CompletedPhilippine Dermatological Society282013-01-012013-11-14
Lithium and Acetate for Canavan Disease
Lithium Gluconate (drug) Glyceryl Triacetate GTA (drug) - Canavan Disease, Infantile
Phase 2WithdrawnAssistance Publique - Hôpitaux de Paris2009-09-012015-04-21
Zinc Supplementation in Type 2 Diabetics
Zinc gluconate, Placebo - Diabetes Mellitus, Non-Insulin-Dependent
Phase 2 / Phase 3CompletedNational University Hospital, Singapore402009-01-012011-03-07
Efficacy of Zinc in Reducing Hyperbilirubinemia Among High Risk Neonates - A Double Blind Randomized Trial
zinc gluconate, placebo - Neonatal Jaundice
Phase 1 / Phase 2CompletedAll India Institute of Medical Sciences2942005-10-012008-06-06
A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer
IRX-2, Cyclophosphamide, Indomethacin - Squamous Cell Carcinoma of the Head and Neck
Phase 2CompletedBrooklyn ImmunoTherapeutics, LLC272005-07-012020-12-11

Conditions studied

Acid-Base Imbalance (1)  ·  Brain Neoplasms (1)  ·  Canavan Disease (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Deficiency Diseases (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Dysphonia (1)  ·  Head and Neck Neoplasms (1)  ·  Hyperbilirubinemia (1)  ·  Jaundice, Neonatal (1)  ·  Mouth Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Warts (1)  ·  Water-Electrolyte Imbalance (1)

Sponsors

All India Institute of Medical Sciences (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Brooklyn ImmunoTherapeutics, LLC (1)  ·  Federal University of São Paulo (1)  ·  Janssen Research & Development, LLC (1)  ·  National University Hospital, Singapore (1)  ·  Philippine Dermatological Society (1)  ·  Tufts University (1)  ·  University of Florida (1)

Countries

United States (3)  ·  Brazil (2)  ·  Argentina (1)  ·  China (1)  ·  France (1)  ·  Germany (1)  ·  India (1)  ·  Malaysia (1)  ·  Philippines (1)  ·  South Korea (1)  ·  Spain (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)

Top investigators

Caroline Sevin, MD, PhD (1)  ·  Jeffrey S. Moyer, MD (1)  ·  Neil Chheda (1)  ·  Nidhi Rana, M.D (1)  ·  Patrick Aubourg, MD, PhD (1)  ·  Raymond CS Seet, MBBS (1)  ·  Rochelle L. Castillo, M.D. (1)

Results publications

PMID 12064356, PMID 15784740, PMID 16002461, PMID 16194720, PMID 20539208, PMID 21284052, PMID 21840002, PMID 22057678, PMID 22109700, PMID 38450236, PMID 40923969, PMID 42876725

NIH funding

2023 (1), R34HL153277 (1)